TP53TG1 and cancer: Moreover, extensive research has shown that TP53TG1 acts as a competitive endogenous RNA (ceRNA), engaging in signaling pathways, modulating gene expression, and influencing the proliferation, migration, invasion, apoptosis, epithelial-mesenchymal transition (EMT), and drug resistance of cancer cells.